Response to Comments: Urinary Biomarkers for Chronic Pain Management

This document is a response-to-comments article about the Proposed Policy on urinary biomarkers for chronic pain management and does not itself establish actionable coverage criteria. No indications, limitations, documentation requirements, or frequency limits are specified here; review the underlying Proposed Policy or final coverage policy for extractable criteria.

"Document is a response-to-comments article and does not specify coverage indications, limitations, documentation requirements, or frequency limits for urinary biomarkers in chronic pain management;..."

Sign up to see full coverage criteria, indications, and limitations.